110
Views
6
CrossRef citations to date
0
Altmetric
Original Research Article

Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia

, , , &
Pages 367-371 | Received 25 Mar 2016, Accepted 05 Jul 2016, Published online: 22 Jul 2016

References

  • Raymond EG, Shannon C, Weaver MA, et al. First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review. Contraception. 2013;87:26–37.
  • World Health Organization. Safe abortion: technical and policy guidance for health systems. 2nd ed. Geneva: WHO; 2012.
  • Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion. Evidence-based clinical guideline number 7. London: RCOG; 2011.
  • Ho PC. Women’s perceptions on medical abortion. Contraception. 2006;74:11–15.
  • Shannon C, Wiebe E, Jacot F, et al. Regimens of misoprostol with mifepristone for early medical abortion: a randomized trial. BJOG. 2006;113:621–8.
  • Akin A, Dabash R, Dilbaz B, et al. Increasing women’s choices in medical abortion: a study of misoprostol 400 μg swallowed immediately or held sublingually following 200 mg mifepristone. Eur J Contracept Reprod Health Care. 2009;14:169–75.
  • Kulier R, Kapp N, Gülmezoglu AM, et al. Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2011;11:CD002855.
  • Chong E, Tsereteli T, Nguyen NN, et al. A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion. Contraception. 2012;86:251–6.
  • Raghavan S, Comendant R, Digol I, et al. Comparison of 400 μg buccal and 400 μg sublingual misoprostol after mifepristone medical abortion through 63 days’ LMP: a randomized controlled trial. Contraception. 2010;82:513–19.
  • Swica Y, Chong E, Middleton T, et al. Acceptability of home use of mifepristone for medical abortion. Contraception. 2013;88:122–7.
  • Louie K, Tsereteli T, Chong E, et al. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan. Eur J Contracept Reprod Health Care. 2014;19:457–64.
  • Louie K, Chong E, Tsereteli T, et al. The introduction of first trimester medical abortion in Armenia. Reprod Health Matters. 2015;22:56–66.
  • Suhonen S, Heikinheimo O, Tikka M, et al. The learning curve is rapid in medical termination of pregnancy – first-year results from the Helsinki area. Contraception. 2003;67:223–7.
  • Hedley A, Trussell J, Turner AN, et al. Differences in efficacy, differences in providers: results from a hazard analysis of medical abortion. Contraception. 2004;69:157–63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.